Overview
3D Systems Q2 revenue declines 16% year-over-year, missing analyst expectations
Net income rises significantly due to gains from asset sales and debt extinguishment
Adjusted EBITDA improves, driven by cost reductions
Outlook
Company anticipates continued impact of tariffs on operating costs
3D Systems expects growth in medical markets to continue
Company projects future growth in Aerospace & Defense market
3D Systems aims for positive cash flow by 2026
Result Drivers
MEDICAL TECHNOLOGY - Double-digit growth in Medical Technology market driven by orthopedic procedures and expansion into trauma-related surgeries
AEROSPACE & DEFENSE - Strong demand in Aerospace & Defense sector, with revenues up 84% year-over-year
COST SAVINGS - Over $20 mln saved in operating expenses through cost reduction and efficiency programs
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Revenue
Miss
$94.80 mln
$95.70 mln (4 Analysts)
Q2 Adjusted EPS
-$0.07
Q2 EPS
$0.57
Q2 Net Income
$104.40 mln
Q2 Adjusted EBITDA
-$5.30 mln
-$13.70 mln (3 Analysts)
Q2 Gross Margin
38.1%
Q2 Adjusted Gross Margin
39.2%
Q2 Operating Income
-$15.40 mln
Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the electronic equipment & parts peer group is "buy."
Wall Street's median 12-month price target for 3D Systems Corp is $2.00, about 11% above its August 8 closing price of $1.78
Press Release: ID:nGNX9vjVk0
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)